Voluntary faculty are typically clinicians or others who are employed outside of the School but make significant contributions to department programs at the medical center or at affiliate institutions.
Voluntary rank detailsMeena S. Moran, MD
Clinical ProfessorAbout
Copy Link
Biography
Dr. Meena S. Moran is the Chief of Breast Radiation Oncology at Yale New Haven Hospital. She is Professor of Therapeutic Radiology at Yale School of Medicine and is internationally recognized as one of the top breast cancer radiation specialists in the world. Dr. Moran has dedicated her career to improving treatment guidelines, national health care delivery, and radiation therapy techniques. She is currently Vice Chair of the National Comprehensive Cancer Network (NCCN) Breast Panel and was one of the founding board members of the National Accreditation Program for Breast Centers (NAPBC) of the American College of Surgeons. Dr. Moran has published more than 150 peer-reviewed scientific articles and has given over 250 national and international professional presentations. She has served on multiple editorial boards including The Journal of Clinical Oncology and is currently an Associate Editor for Breast Cancer Research Treatment.
Appointments
Therapeutic Radiology
Clinical ProfessorPrimary
Other Departments & Organizations
Education & Training
- Resident
- Yale-New Haven Hospital (1998)
- Intern
- Roosevelt Hospital, Columbia University (1995)
- MD
- Cornell University Medical College (1994)
Research
Copy Link
Overview
Medical Research Interests
ORCID
0000-0002-4815-1313
Research at a Glance
Yale Co-Authors
Publications Timeline
Research Interests
Jun Deng, PhD, DABR, FAAPM, FASTRO
Zhe Jay Chen, PhD, DABR, FASTRO, FAAPM
Bruce Haffty, MD
Barbara A Ward, MD, FACS
Christin A. Knowlton, MD, MA
Jay Moran, MD
Radiotherapy, Adjuvant
Radiotherapy
Quality of Health Care
Breast
Complementary Therapies
Publications
2024
Underuse of Postoperative Radiation After Nipple-Sparing Mastectomy for Standard Radiation Indications
Talcott W, Marta G, Moran M. Underuse of Postoperative Radiation After Nipple-Sparing Mastectomy for Standard Radiation Indications. Advances In Radiation Oncology 2024, 9: 101569. PMID: 39188995, PMCID: PMC11345291, DOI: 10.1016/j.adro.2024.101569.Peer-Reviewed Original ResearchCitationsAltmetricConceptsPost-operative radiationNipple-sparing mastectomyRegional nodal irradiationAdverse pathologic featuresOverall survivalPathological featuresEarly-stage breast cancerNational Cancer DatabasePost-operative settingType of surgeryHigh-risk subgroupsNipple preservationNodal irradiationPN+ ratePositive marginsRadiation deliveryInvasive carcinomaSurgical subtypesCancer DatabaseLymph nodesPatient selectionPN+Breast cancerCox regressionMultivariate analysisReply to G.B. Mann et al and S. Sorscher
Jagsi R, Griffith K, Harris E, Wright J, Recht A, Taghian A, Lee L, Moran M, Small W, Johnstone C, Rahimi A, Freedman G, Muzaffar M, Haffty B, Horst K, Powell S, Sharp J, Sabel M, Schott A, El-Tamer M. Reply to G.B. Mann et al and S. Sorscher. Journal Of Clinical Oncology 2024, 42: 1998-2000. PMID: 38489573, DOI: 10.1200/jco.24.00224.Commentaries, Editorials and Letters
2023
Omission of Radiotherapy After Breast-Conserving Surgery for Women With Breast Cancer With Low Clinical and Genomic Risk: 5-Year Outcomes of IDEA
Jagsi R, Griffith K, Harris E, Wright J, Recht A, Taghian A, Lee L, Moran M, Small W, Johnstone C, Rahimi A, Freedman G, Muzaffar M, Haffty B, Horst K, Powell S, Sharp J, Sabel M, Schott A, El-Tamer M. Omission of Radiotherapy After Breast-Conserving Surgery for Women With Breast Cancer With Low Clinical and Genomic Risk: 5-Year Outcomes of IDEA. Journal Of Clinical Oncology 2023, 42: 390-398. PMID: 38060195, PMCID: PMC11846025, DOI: 10.1200/jco.23.02270.Peer-Reviewed Original ResearchCitationsAltmetricConceptsBreast-conserving surgeryIpsilateral breast eventsEndocrine therapyPostmenopausal patientsBreast cancerCrude rateLower riskBreast cancer-specific survival ratesUnifocal invasive breast cancersYears of ETCancer-specific survival ratesStage I breast cancerHuman epidermal growth factor receptor 2Epidermal growth factor receptor 2Omission of radiotherapyYounger postmenopausal patientsPatients age 50Primary end pointBreast conserving surgeryGrowth factor receptor 2I breast cancerInvasive breast cancerRecurrence 5 yearsPatients age 65Single-arm trialPhysician’s comfort level with observing ductal carcinoma in situ of the breast: a survey of breast specialists at accredited breast centers in the United States
Poli E, Chang C, Bleicher R, Moran M, Dietz J, Sarantou T, Kurtzman S, Yao K. Physician’s comfort level with observing ductal carcinoma in situ of the breast: a survey of breast specialists at accredited breast centers in the United States. Annals Of Breast Surgery 2023, 0: 0-0. DOI: 10.21037/abs-22-1.Peer-Reviewed Original ResearchCitations
2022
Radiation Therapy for Low-Risk Breast Cancer: Whole, Partial, or None?
Moran M, Ho A. Radiation Therapy for Low-Risk Breast Cancer: Whole, Partial, or None? Journal Of Clinical Oncology 2022, 40: 4166-4172. PMID: 36332170, DOI: 10.1200/jco.22.01751.Peer-Reviewed Reviews, Practice Guidelines, Standards, and Consensus StatementsCitationsAltmetricMeSH Keywords and ConceptsConceptsWide local excisionPartial breast irradiationBreast cancerRadiation therapyEstrogen receptor-positive/progesteroneLow-risk breast cancerOncology Grand Rounds seriesHuman epidermal growth factor receptor 2Left-sided breast cancerWhole breast radiation therapyEpidermal growth factor receptor 2Clinical-pathologic featuresPostmenopausal female patientsDose/fractionationGrowth factor receptor 2Sentinel node biopsyOmission of radiationCommon clinical scenariosFactor receptor 2Node biopsyPostoperative radiationLocal excisionFemale patientsBreast irradiationTreatment recommendationsDecreasing the Interval Wait Times for Screening Mammogram Results Using the “Reflex Testing” Algorithm
Alvarenga J, Moran J, Bulgaru A, Moran M. Decreasing the Interval Wait Times for Screening Mammogram Results Using the “Reflex Testing” Algorithm. Journal Of Breast Imaging 2022, 4: 474-479. PMID: 38416949, DOI: 10.1093/jbi/wbac043.Peer-Reviewed Original ResearchCitationsAltmetricConceptsFirst diagnostic testReflex testingDiagnostic testsScreening mammogramsBI-RADS 0Date of biopsyAdditional diagnostic testingAbnormal screening mammogramPearson chi-square analysisWait timeAnalytic cohortMammogram resultsSix-month periodBreast centerChi-square analysisDiagnostic testingBiopsyPatientsInterventionCohortDaysMammogramsElapsed daysTestingReflex
2020
2017
Radiation Oncology Considerations in the Management of Mutation Carriers with Breast Cancer
Moran M. Radiation Oncology Considerations in the Management of Mutation Carriers with Breast Cancer. 2017, 151-170. DOI: 10.1007/978-3-319-59198-8_9.ChaptersConceptsBreast cancerMutation carriersRadiation therapyLocal-regional managementPost-mastectomy settingBreast conservation therapyBRCA mutation carriersTreatment management decisionsBRCA mutation statusHereditary breast cancerBreast conservationTNBC patientsConservation therapyBRCA carriersFamily historyMutation statusRadiation therapy deliveryTreatment conceptGenetic testingBRCA genesCancerTherapyStrong associationTherapy deliveryPresent guidelines
2016
Society of Surgical Oncology–American Society for Radiation Oncology–American Society of Clinical Oncology Consensus Guideline on Margins for Breast-Conserving Surgery With Whole-Breast Irradiation in Ductal Carcinoma In Situ
Morrow M, Van Zee KJ, Solin LJ, Houssami N, Chavez-MacGregor M, Harris JR, Horton J, Hwang S, Johnson PL, Marinovich ML, Schnitt SJ, Wapnir I, Moran MS. Society of Surgical Oncology–American Society for Radiation Oncology–American Society of Clinical Oncology Consensus Guideline on Margins for Breast-Conserving Surgery With Whole-Breast Irradiation in Ductal Carcinoma In Situ. Journal Of Clinical Oncology 2016, 34: 4040-4046. PMID: 27528719, PMCID: PMC5477830, DOI: 10.1200/jco.2016.68.3573.Peer-Reviewed Original ResearchCitationsAltmetricMeSH Keywords and ConceptsConceptsIpsilateral breast tumor recurrenceWhole breast irradiationRisk of IBTRNegative marginsDuctal carcinomaRate of IBTRSurgical Oncology–American SocietyMargin widthMultidisciplinary consensus panelBreast tumor recurrenceBreast conserving surgeryBreast-conserving surgeryNegative margin widthOptimal negative margin widthRe-excision ratesHealth care costsFurther surgeryPositive marginsBreast irradiationConsensus guidelinesCosmetic outcomeTumor recurrenceClear marginsConsensus panelBackground ControversyLa Danse d'un Cygne (The Dance of a Swan)
Moran M. La Danse d'un Cygne (The Dance of a Swan). International Journal Of Radiation Oncology • Biology • Physics 2016 DOI: 10.1016/j.ijrobp.2016.06.2451.Peer-Reviewed Original ResearchAltmetric
Academic Achievements & Community Involvement
Copy Link
Activities
activity American College of Radiology
07/01/2009 - PresentCommitteesMemberDetailsBreast Expert Panel-Radiation Oncology, Appropriateness Criteria Committeeactivity Member
2009 - PresentCommitteesCommittee MemberDetails3rd Annual American Society of Clinical Oncology Breast Symposium,activity American Society of Therapeutic Radiology & Oncology (ASTRO)
2006 - 2012Professional OrganizationsMemberDetailsModerator, presenter, discussant, committee memberactivity Member
2008 - 2012CommitteesMemberDetailsInformation Technology Committeeactivity American Radium Society (ARS)
2008 - 2010Professional OrganizationsMemberDetailsModerator, faculty, discussant, committees
News
Copy Link
News
- June 06, 2025
Yale Cancer Center Researchers and Trainees Present at 2025 ASCO Annual Meeting
- October 29, 2024
Smilow Shares Breast Cancer Awareness: Empowered through Knowledge, Smilow at Waterford/Westerly
- September 20, 2024Source: Everyday Health
Is There Any Way to Minimize Side Effects of Radiation for Breast Cancer?
- October 13, 2022Source: YNHH Lawrence Memorial Hospital
Advancing Care - October 2022
Get In Touch
Copy Link